- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/72 - Heterocyclic compounds containing 1,3,5-triazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 251/72
Total number of patents in this class: 17
10-year publication summary
|
3
|
1
|
0
|
2
|
0
|
1
|
0
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| National Institute of Biological Sciences, Beijing | 101 |
2 |
| Corteva Agriscience LLC | 2644 |
2 |
| Bristol-myers Squibb Company | 4757 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 780 |
1 |
| AMOREPACIFIC Corporation | 2908 |
1 |
| BioLab Ltd. | 5 |
1 |
| The Broad Institute, Inc. | 1986 |
1 |
| Crystalgenomics, Inc. | 47 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
1 |
| Qbi Enterprises Ltd. | 6 |
1 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
1 |
| Sekisui Chemical Co., Ltd. | 3633 |
1 |
| Crinetics Pharmaceuticals, Inc. | 132 |
1 |
| Industry-Academic Cooperation Foundation, Yonsei University of Yonsei University | 1 |
1 |
| NRG Therapeutics Ltd | 19 |
1 |
| Other owners | 0 |